Showing results (31-40 of 112) with videos related to

Sort By:
Pageof 12
BMC Cancer|May 3, 2022
Dual targeting of FGFR3 and ERBB3 enhances the efficacy of FGFR inhibitors in FGFR3 fusion-driven bladder cancerAndrew J Weickhardt, David K Lau, Margeaux Hodgson-Garms, et al.
The Journal of Biological Chemistry|March 15, 2006
Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancerAndrew J Wilson, Do-Sun Byun, Natalia Popova, et al.
Frontiers in Oncology|November 17, 2022
Potentiating effect of reovirus on immune checkpoint inhibition in microsatellite stable colorectal cancerTitto Augustine, Peter John, Tyler Friedman, et al.
Cancer Medicine|May 6, 2023
Induction of endoplasmic reticulum stress is associated with the anti-tumor activity of monepantel across cancer typesTiffany J Harris, Yang Liao, Wei Shi, et al.
British Journal of Cancer|March 13, 2018
Phase II study of everolimus (RAD001) monotherapy as first-line treatment in advanced biliary tract cancer with biomarker exploration: the RADiChol StudyDavid K Lau, Rebecca Y Tay, Yvonne H Yeung, et al.
Cancer Research|December 26, 2003
Gene expression profiling-based prediction of response of colon carcinoma cells to 5-fluorouracil and camptothecinJohn M Mariadason, Diego Arango, Qiuhu Shi, et al.
Molecular Oncology|May 26, 2017
K-Ras mutation and amplification status is predictive of resistance and high basal pAKT is predictive of sensitivity to everolimus in biliary tract cancer cell linesYvonne Yeung, David K Lau, Fiona Chionh, et al.
Gastroenterology|July 17, 2007
p27kip1 Regulates cdk2 activity in the proliferating zone of the mouse intestinal epithelium: potential role in neoplasiaHelena J M Smartt, Sandra Guilmeau, Shannon V Nasser, et al.
Oncotarget|January 11, 2014
FOXP3 over-expression inhibits melanoma tumorigenesis via effects on proliferation and apoptosisBeeShin Tan, Matthew Anaka, Siddhartha Deb, et al.
Investigational New Drugs|July 3, 2009
Intravenous administration of Reolysin, a live replication competent RNA virus is safe in patients with advanced solid tumorsRadharani Gollamudi, Mohammad H Ghalib, Kavita K Desai, et al.
Pageof 12